• Micro- and Nanoplastics Heighten Pulmonary Fibrosis via FXR-

  2026-05-12

  This study systematically compares the pulmonary toxicity of microplastics and nanoplastics by polymer type and size, revealing that both significantly increase the risk of pulmonary fibrosis in vivo and in vitro. Mechanistic findings implicate the FXR-YAP1 axis in mediating these effects, with polystyrene nanoplastics showing the greatest toxicity, offering new insight into how plastic pollution impacts respiratory health.

• (-)-Arctigenin: MEK1 Inhibitor for Tumor Microenvironment St

  2026-05-12

  (-)-Arctigenin stands out as a precision MEK1 inhibitor, enabling researchers to dissect the tumor microenvironment with unmatched pathway selectivity. Its dual action on NF-κB and MAPK/ERK cascades positions it as a critical tool for studies on inflammation, metastasis, and antiviral mechanisms.

• Broad-Spectrum Bivalent mRNA Vaccine RQ3025 Counters SARS-Co

  2026-05-11

  This article examines the preclinical evaluation of the bivalent mRNA vaccine RQ3025, designed to induce broad neutralizing antibody responses against a spectrum of SARS-CoV-2 variants. The study demonstrates RQ3025’s superior immunogenicity and safety in animal models, providing key insights into vaccine design for emerging viral threats.

• Salmonella Haem Biosynthesis Regulates Macrophage Phagocytos

  2026-05-11

  This study uncovers a methyltransferase-driven mechanism by which Salmonella Typhimurium enhances haem biosynthesis to evade macrophage phagocytosis and promote infection in mice. The findings highlight the centrality of heme pathway regulation in bacterial virulence and open avenues for dissecting immune evasion strategies using targeted biochemical assays.

• Dextran Sulfate Sodium Salt (MW 35000-45000): Next-Gen Model

  2026-05-10

  Explore how Dextran sulfate sodium salt (MW 35000-45000) enables advanced modeling of mucosal injury and repair in inflammatory bowel disease research. This article uniquely bridges molecular circuitry insights with practical protocol optimization for translational ulcerative colitis studies.

• Moxidectin Synergizes with Polyenes by Elevating Fungal Ergo

  2026-05-09

  This study demonstrates that moxidectin, a macrocyclic lactone anthelmintic, potentiates the antifungal effects of polyenes against Candida albicans by upregulating ergosterol biosynthesis. The findings reveal a mechanistic basis for combination therapy with moxidectin and polyenes, offering a promising strategy to improve treatment outcomes in oral candidiasis.

• Bacteria-Derived OMVs Enable Rapid mRNA Antigen Display for

  2026-05-08

  This study introduces a novel platform using genetically engineered bacterial outer membrane vesicles (OMVs) to rapidly display mRNA antigens for personalized tumor vaccine development. The approach achieves robust antigen delivery and immune activation, offering a distinct alternative to lipid nanoparticle-based systems and addressing key challenges in mRNA vaccine customization.

• Capsazepine in Translational Pain Research: Mechanisms & Ass

  2026-05-08

  Explore how Capsazepine, a TRPV1 ion channel antagonist, enables advanced translational pain and apoptosis research. This article delivers unique insights on protocol optimization and mechanistic nuances that set it apart from existing resources.

• HyperFluor 488 Goat Anti-Human IgG: Precision in Immunofluor

  2026-05-07

  The HyperFluor 488 Goat Anti-Human IgG (H+L) Antibody is a polyclonal, Alexa Fluor 488-conjugated secondary antibody providing high specificity and sensitivity for human immunoglobulin detection. This reagent enables robust signal amplification in immunoassays such as immunofluorescence, Western blot, and flow cytometry, supporting reproducible translational research. Its performance is validated for minimal cross-reactivity and optimized stability.

• Micro- and Nanoplastics Drive Pulmonary Fibrosis via FXR-YAP

  2026-05-07

  This study provides systematic evidence that inhaled microplastics and nanoplastics, especially polystyrene nanoplastics, induce pulmonary fibrosis by disrupting the FXR-YAP1 signaling axis. Findings highlight the size- and polymer-dependent toxicity of emerging plastic pollutants, offering mechanistic insights for respiratory risk assessment.

• Bufalin Targets STK33: Mechanistic Advances in TNBC Research

  2026-05-06

  This study identifies Serine/Threonine Kinase 33 (STK33) as a novel and actionable target of the cardiotonic steroid Bufalin in triple-negative breast cancer (TNBC). Through multi-platform binding and degradation assays, the authors reveal how Bufalin disrupts STK33 stability, offering mechanistic and translational insights for future TNBC therapies.

• Affinity-Purified Goat Anti-Rabbit IgG (H+L): Mechanisms & A

  2026-05-06

  Discover the science behind Affinity-Purified Goat Anti-Rabbit IgG (H+L), a horseradish peroxidase conjugated secondary antibody. This article uniquely explores its molecular mechanism, practical assay optimization, and lessons from recent apoptosis research for advanced immunoassays.

• Halazone: Molecular Mechanisms and Precision Disinfection Sc

  2026-05-05

  Explore Halazone as a cutting-edge antimicrobial sulfonamide derivative, with a deep dive into its molecular mechanisms, stability, and advanced applications in water disinfection and neurophysiology. Uncover new insights for assay optimization and experimental design.

• Unlocking Translational Precision: HyperFluor™ 488 in Immune

  2026-05-05

  This thought-leadership article explores how the HyperFluor™ 488 Goat Anti-Human IgG (H+L) Antibody advances immunoassay sensitivity, reproducibility, and mechanistic insight for translational researchers. By weaving together mechanistic rationale, recent breakthroughs in mRNA vaccine development, and rigorous workflow optimization, we articulate clear strategic guidance for leveraging advanced fluorescent secondary antibodies in next-generation immunodetection, and clarify how this approach bridges preclinical innovation and real-world diagnostic needs.

• Wnt/β-catenin Inhibition Fails to Alleviate DSS-Induced Coli

  2026-05-04

  This study rigorously tested the therapeutic value of XAV939, a Wnt/β-catenin pathway inhibitor, in a dextran sulfate sodium-induced ulcerative colitis (UC) mouse model. Despite effectively suppressing Wnt/β-catenin signaling and SOX9 expression, XAV939 did not reduce intestinal inflammation or restore key epithelial markers, suggesting that this pathway is not the predominant driver of inflammation in this UC model.

16368 records 1/1092 page Next 12345 下5页 Last page